PI3K is critical for the nuclear translocation of IRF-7 and type IIFN production by human plasmacytoid predendritic cells in response to TLR activation

被引:189
作者
Guiducci, Cristiana [1 ]
Ghirelli, Cristina [2 ,3 ]
Marloie-Provost, Marie-Annick [2 ]
Matray, Tracy [1 ]
Coffman, Robert L. [1 ]
Liu, Yong-Jun [4 ]
Barrat, Franck J. [1 ]
Soumelis, Vassili [2 ,3 ]
机构
[1] Dynavax Technol Corp, Berkeley, CA 94710 USA
[2] Inst Curie, Dept Immunol, F-75005 Paris, France
[3] Inst Natl Sante & Rech Med, U653, F-75005 Paris, France
[4] Univ Texas Houston, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA
关键词
D O I
10.1084/jem.20070763
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Plasmacytoid predendritic cells (pDCs) are the main producers of type I interferon (IFN) in response to Toll-like receptor (TLR) stimulation. Phosphatidylinositol-3 kinase (PI3K) has been shown to be activated by TLR triggering in multiple cell types; however, its role in pDC function is not known. We show that PI3K is activated by TLR stimulation in primary human pDCs and demonstrate, using specific inhibitors, that PI3K is required for type I IFN production by pDCs, both at the transcriptional and protein levels. Importantly, PI3K was not involved in other proinflammatory responses of pDCs, including tumor necrosis factor alpha and interleukin 6 production and DC differentiation. pDCs preferentially expressed the PI3K delta subunit, which was specifically involved in the control of type I IFN production. Although uptake and endosomal trafficking of TLR ligands were not affected in the presence of PI3K inhibitors, there was a dramatic defect in the nuclear translocation of IFN regulatory factor (IRF) 7, whereas nuclear factor kappa B activation was preserved. Thus, PI3K selectively controls type I IFN production by regulating IRF-7 nuclear translocation in human pDCs and could serve as a novel target to inhibit pathogenic type I IFN in autoimmune diseases.
引用
收藏
页码:315 / 322
页数:8
相关论文
共 35 条
[1]   Nucleic acids of mammalian origin can act as endogenous ligands for toll-like receptors and may promote systemic lupus erythematosus [J].
Barrat, FJ ;
Meeker, T ;
Gregorio, J ;
Chan, JH ;
Uematsu, S ;
Akira, S ;
Chang, B ;
Duramad, O ;
Coffman, RL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (08) :1131-1139
[2]   Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis [J].
Camps, M ;
Rückle, T ;
Ji, H ;
Ardissone, V ;
Rintelen, F ;
Shaw, J ;
Ferrandi, C ;
Chabert, C ;
Gillieron, C ;
Françon, B ;
Martin, T ;
Gretener, D ;
Perrin, D ;
Leroy, D ;
Vitte, PA ;
Hirsch, E ;
Wymann, MP ;
Cirillo, R ;
Schwarz, MK ;
Rommel, C .
NATURE MEDICINE, 2005, 11 (09) :936-943
[3]   Plasmacytoid dendritic cell-specific receptor ILT7-FcεRIγ inhibits Toll-like receptor-induced interferon production [J].
Cao, Wei ;
Rosen, David B. ;
Ito, Tomoki ;
Bover, Laura ;
Bao, Musheng ;
Watanabe, Gokuran ;
Yao, Zhengbin ;
Zhang, Li ;
Lanier, Lewis L. ;
Liu, Yong-Jun .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (06) :1399-1405
[4]   Plasmacytoid dendritic cells in immunity [J].
Colonna, M ;
Trinchieri, G ;
Liu, YJ .
NATURE IMMUNOLOGY, 2004, 5 (12) :1219-1226
[5]   Toll-like receptors and IFN-α:: partners in autoimmunity [J].
Colonna, Marco .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (09) :2319-2322
[6]   Regulation of IFN regulatory factor-7 and IFN-α production by enveloped virus and lipopolysaccharide in human plasmacytoid dendritic cells [J].
Dai, JH ;
Megjugorac, NJ ;
Amrute, SB ;
Fitzgerald-Bocarsly, P .
JOURNAL OF IMMUNOLOGY, 2004, 173 (03) :1535-1548
[7]   Phosphoinositide 3-kinase: Diverse roles in immune cell activation [J].
Deane, JA ;
Fruman, DA .
ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 :563-598
[8]   IL-10 regulates plasmacytoid dendritic cell response to CpG-containing immunostimulatory sequences [J].
Duramad, O ;
Fearon, KL ;
Chan, JH ;
Kanzler, H ;
Marshall, JD ;
Coffman, RL ;
Barrat, FJ .
BLOOD, 2003, 102 (13) :4487-4492
[9]   Inhibitors of TLR-9 act on multiple cell subsets in mouse and man in vitro and prevent death in vivo from systemic inflammation [J].
Duramad, O ;
Fearon, KL ;
Chang, B ;
Chan, JH ;
Gregorio, J ;
Coffman, RL ;
Barrat, FJ .
JOURNAL OF IMMUNOLOGY, 2005, 174 (09) :5193-5200
[10]   BDCA-2, a novel plasmacytoid dendritic cell-specific type IIC-type lectin, mediates antigen capture and is a potent inhibitor of interferon α/β induction [J].
Dzionek, A ;
Sohma, Y ;
Nagafune, J ;
Cella, M ;
Colonna, M ;
Facchetti, F ;
Günther, G ;
Johnston, I ;
Lanzavecchia, A ;
Nagasaka, T ;
Okada, T ;
Vermi, W ;
Winkels, G ;
Yamamoto, T ;
Zysk, M ;
Yamaguchi, Y ;
Schmitz, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (12) :1823-1834